Alector Inc (ALEC) Sector
Health Care

(Current) $6.23
0.33 (5.59%) Open Price: 6.23

Alector Inc is a clinical-stage biopharmaceutical company that is focused on the development of innovative therapies for the treatment of neurodegenerative diseases. The company is based in South San Francisco, California, and was founded in 2013. Alector's mission is to develop first-in-class therapies that target the underlying causes of neurodegeneration, with the ultimate goal of improving the lives of patients with these devastating diseases.

Alector's product pipeline includes several promising drug candidates that are designed to address the underlying causes of neurodegeneration, including Alzheimer's disease, Parkinson's disease, and ALS. The company's approach is based on the latest insights into the molecular and cellular mechanisms of neurodegeneration, with a focus on targeting specific pathways and mechanisms that are believed to be involved in the disease process. Alector's drug candidates have shown promising results in early clinical trials, and the company is currently conducting phase 2 trials to evaluate the safety and efficacy of these therapies in larger patient populations.

Alector is committed to innovation and collaboration, and is working closely with leading academic and industry partners to advance the field of neurodegenerative disease research. The company has a strong management team with deep experience in drug development and commercialization, and is well-funded with significant financial support from leading biotech investors. With a strong pipeline of innovative drug candidates, a focus on collaboration and innovation, and a commitment to improving the lives of patients with neurodegenerative diseases, Alector is well-positioned to continue making significant strides in this important field of medicine.


(04/11/24) $6.23
(04/12/24) $5.90
(04/12/24) (Qty.)791,888
(04/11/24) $5.87
(04/11/24) $6.25
(01/14/24) $5.49
(01/14/24) $7.78
LetsEncrypt SSL Secure Stripe Payment Processing